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Abstract: 
Silybum marianum (Milk thistle) has been used in the treatment of various 
diseases including liver diseases and the prevention and treatment of cancer 
and has also been known to be used as food. Therefore, in the present 
research, the safety usage of milk thistle extract and its ability to alleviate 
doxorubicin-induced toxicity in rats was examined. Male Wistar rats were divided 
into 4 groups, 1
st
 group was used as control, the 2
nd
, 3
rd,
 and 4
th
 groups 
administrated plant extract (100 mg/ml/Kg, orally), doxorubicin (15 mg/kg, i.p.) 
and plant extract plus doxorubicin respectively for 15 days except for 
doxorubicin which was injected on the 14
th
 day. Data of present research proved 
the ability of milk thistle extract to alleviate doxorubicin-induced toxicity on 
various biochemical and hematological parameters, regulation of COX1 gene 
expression level as well as decreasing plasma and liver TBARS and increasing 
total antioxidant capacity, reduced GSH, GST, and GPx that minimized oxidative 
stress induced by the drug. In conclusion, milk thistle extract could be used 
during doxorubicin chemotherapy treatment as a natural source to avoid the side 
effects induced by this chemotherapeutic agent. 
Keywords: Milk thistle, liver diseases, male Wistar rats, doxorubicin, 
chemotherapy. 
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INTRODUCTION 
Doxorubicin commercially known as 
Adriamycin is a chemotherapeutic drug used to 
treat cancer. This includes lymphoma, acute 
lymphocytic leukemia, breast cancer, and 
bladder cancer. It is frequently used together 
with other chemotherapeutic agents. 
Doxorubicin is injected through the vein (The 
American Society of Health-System 
Pharmacists, 2017). Doxorubicin induces 
oxidative stress (Mai et al., 2016). Most 
chemotherapeutic agents' major mechanism for 
cytotoxicity to normal cells is due to their 
oxidative damage (Joshi et al., 2001). 
The popularity of complementary and 
alternative medicine (CAM) has increased 
primarily herbal medicine (Shahzad et al., 2017; 
Iqbal and Ashraf, 2019a; Iqbal and Ashraf, 
2019b). Its acceptance among physicians has 
increased despite the ongoing debate of 
integrating it into mainstream healthcare (Joos et 
al., 2011). 
Mediterranean milk thistle, blessed milk, 
Mary thistle, milk thistle, Scotch thistle, and 
variegated thistle are common names for 
Silybum marianum (Natural Resources 
Conservation Service, 2015). This practically 
characteristic thistle has glistening light green 
leaves with white veins and purple to red 
flowers. Initially a local of Southern Europe 
through to Asia, it is currently originated all over 
the globe. It has been used in Europe to prevent 
hepatic and biliary disorders, protect liver and 
kidneys from toxicity induced by medications as 
well as being an antidote for Amanita mushroom 
poisoning. The German Commission E 
recommends it for the treatment of dyspeptic 
complaints, toxin-induced liver damage, and 
hepatic cirrhosis and as supportive therapy for 
chronic inflammatory liver conditions (El-Kamary 
et al., 2009). 
Milk thistle is a family Asteraceae, which 
is one of the most widely used medicinal plants. 
It has been useful in the treatment of a range of 
liver and gall bladder disorders, including 
hepatitis, jaundice and cirrhosis, and protection 
of liver poisoning from environmental toxins, 
including insect stings, snakebites, mushroom 
poisoning and alcohol and chemicals (Abenavoli 
et al., 2010). Silybum marianum contains 
numerous hepatoprotective bioactive molecules 
such as lipids, in the form of linoleic, oleic and 
palmitic acid and flavonoids including quercetin, 
eriodictyol, taxifolin, and chrysoeriol. It was 
proved the constituents responsible for the 
activity are flavanolignans (flavanone 
derivatives) initially isolated as a mixture of 
addition products of a coniferyl alcohol, 
phenylpropanoid alcohol, and a 2, 3-
dihydroflavonol, taxifolin. This mixture’s name is 
silymarin and consists of silybin isosilibin, 
silychristin and silydianin, in addition to silimonin, 
isosilibinin and isosilychristin (Wu et al., 2009). 
Silymarin converts reactive oxygen species 
(ROS) to harmless molecules and stops the 
reduction in glutathione and superoxide 
dismutase concentrations (El-Shitany et al., 
2008). Silymarin was proved to increase the 
uptake and actions of chemotherapeutic agents 
as suggested by several in vitro and in vivo 
studies. In vitro and animal, data suggest that 
silymarin may increase the uptake and actions of 
chemotherapeutic agents. Preclinical 
investigations emphasized that silymarin 
increased daunomycin accumulation, 
potentiated doxorubicin activity, and inhibited the 
efflux of these drugs from cancer cells (Colombo 
et al., 2011). 
The present research aimed to use milk 
thistle extract as a mixture of antioxidants to 
alleviate oxidative stress-induced toxicity by 
doxorubicin.  
 
MATERIALS AND METHODS 
Chemicals 
Doxorubicin was obtained from Sigma 
Chemical Company; St Louis, MO, USA. The 
dose selection for doxorubicin was used 
  
Biological Research                                          2020;  5(1): 14-21   
 
16 
                                                             PSM Biological Research | https://journals.psmpublishers.org/index.php/biolres 
according to the previous work of Mello et al. 
(2017). 
Ethical approval 
This research was carried out at the 
Pharmaceutical and Fermentation Industries 
Development Center in the City of Scientific 
Research and Technological Applications 
(SRTA-city) and approved by its ethics 
committee (IACUCs) l IACU # 11-1H-1019. 
Safety assay of using milk thistle extract 
Neutral red assay protocols were used to 
quantify the safety patterns of plant extract on 
preferable blood mononuclear cells (PBMCs) 
cells using neutral red assay protocols. Briefly, 
about, 6X10
4
 cells/ml cell suspension was 
seeded in 96 well plates and incubated at 37°C 
in 5% CO2 incubator till semiconfluency. After 24 
hrs., the exhausted media were discarded and 
replaced with serially diluted plant extract 
prepared in RPMI media. The inoculated plates 
were incubated for 48 hrs., the Cytotoxicity 
percentages of the plant extract were quantified 
using neutral red. 
Preparation of plant extract 
Silybum marianum extract prepared in 
which 100 gm wet plant was dissolved in 100 ml 
distilled water and boiled for 5 minutes, 
homogenized and filtered then lyophilized. The 
doses were prepared in which 1gm was 
dissolved in every 10 ml.    
Experimental animals 
Thirty-six male Wistar rats (140–170 g) 
were used in this study. Rats were kept on basal 
diet and tap water which were provided ad 
libitum and were kept under standard conditions 
which conformed to the National Institutes of 
Health (NIH) guidelines. Animals were divided 
into four groups after 14 days of acclimation, 9 
rats each in which control was the first group, 
the second, third and fourth administrated the 
plant extract (100 mg/kg BW, orally), doxorubicin 
(15 mg/kg BW, IP), the plant extract plus 
doxorubicin respectively. The experiment was 
performed for 14 days, doses of the extract were 
given daily but doxorubicin was given on 14th 
day. 
Blood collection and tissue preparation 
24 hrs after the last injection, blood 
samples were collected from the sacrificed 
animals then placed on ice, then they were 
centrifuged for 20 min at 3000 rpm, the obtained 
plasma was stored at −80°C. Tissues samples 
were separately minced and homogenized in 
ice-cold sodium and potassium phosphate buffer 
(0.01 M, pH 7.4). The homogenate was 
centrifuged for 20 min at 4°C at 3,000 rpm and 
the supernatant was used. 
Quantification of liver COX1  
 At the end of the in vivo study, RNA 
extraction kit purchased from Thermo scientific 
was used to extract total liver RNAs. Strand 
cDNA synthesis Thermo scientific purchased kit 
was used to synthesize cDNA. Real-time 
polymerase chain reaction (Rt-PCR) was 
conducted using β-actin as an internal control 
reference by Qiagen Syber Green master mix. 
Table (1) illustrates the list of used primers. 
 
Table 1. The list of primers used in gene expression 
analysis. 
Primers Sequence 
Cox-1 F. 5′-AGGAGATGGCTGCTGAGTTGG-3′ 
R. 5′-AATCTGACTTTCTGAGTTGCC-3′ 
β-actin F. 5'- GTGGGGCGCCCCAGGCACCA -3' 
R. 5'- CTCCTTAATGTCACGCACGATTTC-3' 
 
Thiobarbituric acid reactive substances and 
antioxidants 
Plasma and liver supernatant 
thiobarbituric acid-reactive substances (TBARS) 
were calculated using the Esterbauer and 
Cheeseman method (1990). Total antioxidant 
capacity was measured by Koracevic et al. 
(2001) method. Reduced glutathione content 
was estimated using Beutler et al. (1963) 
method. 
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Biochemical parameters 
Kits from BioSystems (Spain) were used 
to examine total protein (Tietz Textbook of 
Clinical Chemistry and Molecular Diagnostics, 
2005), albumin (Tietz Textbook of Clinical 
Chemistry and Molecular Diagnostics, 2012), 
urea, creatinine, LDH (lactate dehydrogenase), 
γ-GT (γ- Glutamyl transferase), ALT (alanine 
transaminase) and AST (aspartate 
transaminase) (Tietz Textbook of Clinical 
Chemistry and Molecular Diagnostics, 2005) in 
stored plasma samples. Whereas thiobarbituric 
acid was purchased from Sigma Chemical 
Company, St Louis, MO, USA. 
Hematological parameters 
Blood samples were collected from the 
animals 24 h after the last dose and placed on 
ice. Heparin was used as an anticoagulant. Red 
Blood cells (RBC), Hemoglobin (HGB), Mean 
corpuscular hemoglobin (MCH), Hematocrit 
(HCT), Mean corpuscular volume (MCV) and 
platelets (PLT) were examined in non-
coagulated blood using HA-VET CLINDIAG 
obtained from Clindiag Systems Co.  
RESULTS 
Safety assays 
The neutral red assay protocol results 
(Table 2 and Figure1) indicated that the usage of 
S. marianum extract didn’t record any significant 
toxicity on PBMCs after 48 hrs. The maximum 
used concentration (10 mg/ml) showed about 
17.3 cytotoxicity percentage on PBMCs cellular 
proliferation. Also, by treating PBMCs cells with 
1.25 mg/ml of plant extract, the cellular 
proliferation rate increase with percentage 
157.82 (Figure 1).  
Bodyweight and Biochemical parameters 
There was no significant change in body 
weight. Treatment with Silybum marianum 
extract alone significantly increased albumin and 
decreased AST. On the other hand, injection 
with doxorubicin alone significantly decreased 
total protein and albumin and increased urea, 
creatinine, LDH, γ-GT. ALT and AST. 
Administration of Silybum marianum extract with 
doxorubicin was able to alleviate its toxicity on 
most of the estimated parameters.  
 
 
 
Fig. 1. Cytotoxicity results of milk thistle extract 
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Table 2. Effect of Silybum marianum extract administration on various parameters. 
Parameters Group 1 Group 2 Group 3 Group 4 
Body weight(gm) 150±5.03
ab 
155±7.99
ab 
127±5.91
b 
154±2.57
ab 
Biochemical     
Total protein (g/L) 75.2±0.66
a 
76.8±0.67
a 
62.6±1.71
b 
63.9±1.42
bc 
Albumin (g/L) 42.6±1.13
b 
57.7±1.41
a 
19.3±0.32
d 
26.4±1.27
c 
Urea (mg/dl) 29.5±2.63
cd 
28.7±2.71
d 
42.5±2.89
a 
35.3±3.12
bc 
Creatinine(mg/dl) 0.91±0.02
c 
0.92±0.01
c 
2.40±0.14
a 
1.74±0.12
b 
LDH(U/L) 170±2.97
c 
169±6.92
c 
435±24.4
a 
311±16.9
b 
γ-GT(U/L) 24.3±0.44
c 
22.4±0.71
c 
35.5±0.67
a 
29.6±1.11
b 
ALT(U/L) 30.3±1.56
c 
28.3±1.13
c 
64.1±3.77
a 
51.3±1.80
b 
AST(U/L) 27.3±1.62
b 
24.4±0.93
c 
38.1±1.45
a 
36.4±0.89
a 
Antioxidants     
Plasma     
TAC(mM/L) 1.01±0.05
b 
1.92±0.04
a 
0.69±0.03
d 
0.84±0.02
c 
TBARS(nmol/ml) 0.72±0.02
c 
0.36±0.01
d 
2.60±0.11
a 
1.55±0.02
b 
GSH(µmole/ml) 4.56±0.16
b 
5.07±0.18
a 
2.88±0.07
c 
4.39±0.21
b 
GPx(U/ml) 8.18±0.18
ab 
8.63±0.29
a 
7.56±0.12
c 
7.84±0.19
bc 
GST(µmol/hr/ml) 1.04±0.08
ab 
1.18±0.06
a 
0.64±0.05
d 
0.93±0.04
bc 
Liver     
TAC(mM/L) 0.77±0.03
b 
0.94±0.01
a 
0.57±0.02
d 
0.68±0.02
c 
TBARS(nmol/gm wet tissue) 27.8±0.53
c 
19.2±1.32
d 
61.7±1.32
a 
29.0±1.53
b 
GSH(
µmole
/gm wet tissue) 6.44±0.16
b 
7.41±0.39
a 
4.85±0.22
c 
5.36±0.21
c 
GPx(U/mg protein) 30.8±0.98
a 
31.7±0.93
a 
24.2±1.12
b 
28.6±1.24
a 
GST(µmol /hr/mg protein) 0.98±0.04
bc 
1.16±0.08
a 
0.78±0.04
d 
0.95±0.05
c 
Hematological     
Plasma RBC's(10
6
 /µL) 7.53±0.09
ab 
7.43±0.14
b 
5.78±0.25
c 
7.95±0.21
ab 
HGB(g/dL) 10.1±0.19
c 
11.5±0.26
b 
8.60±0.26
d 
12.5±0.23
a 
HCT(%) 35.2±0.53
c 
38.0±1.52
b 
29.4±1.66
d 
39.5±1.77
a 
MCV(fL) 46.6±1.75
c 
48.4±2.37
ab 
43.2±1.34
c 
50.7±0.26
a 
MCH(Pg) 12.9±0.54
c 
13.9±0.29
ab 
13.7±0.76
ab 
15.4±0.53
a 
PLT(10
3
/µL) 356±17.6
a 
332±18.7
a 
170±16.6
c 
284±32.7
b 
Data are presented as Mean ± S.E, S.E: Standard Error. Mean values within a row not sharing common superscript 
letters (a, b, c, d) were significantly different, p<0.05. Group 1: control group, Group 2: Plant extract group, Group 3: 
Doxorubicin group, Group 5: Plant extract + doxorubicin group. 
 
 
Fig. 2. Gene expression results in liver COX1 gene. 
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Hematological parameters 
Silymarin administration significantly 
increased HGB and HCT whereas RBC, HGB, 
HCT, and PLT were decreased in rats treated 
with doxorubicin while MCH increased. 
Treatment with Silybum marianum extract with 
doxorubicin minimized its toxic effect on these 
measured parameters.  
Oxidative stress and antioxidants 
Doxorubicin injection significantly 
increased plasma and liver TBARS and 
decreased their TAC, GSH, GST, and GPx. 
Whereas Silybum marianum extract 
administration overcame the harmful effect of 
oxidative stress induced by doxorubicin via 
decreasing plasma and liver TBARS and 
increasing TAC and various antioxidants in rats. 
Gene Expression 
COX-1 expression was increased upon 
treatment with doxorubicin whereas Silymarin 
treatment decreased this elevation (Figure 2). 
 
DISCUSSION 
Rašković et al. (2011) suggested that 
silymarin prevented the dramatic loss in body 
weight than the group treated with doxorubicin 
alone although this decrease was not significant. 
They concluded that doxorubicin causes 
irreversible heart failure and confirmed the ability 
of silymarin to minimize the increase in 
myocardial excitability caused by the drug. 
Rašković et al. (2011) explained that the 
semiquinone form of doxorubicin causes the 
production of free radicals via interacting with 
molecular oxygen, these free radicals are 
responsible for its cardio and hepatotoxicity. 
Silymarin acts as a strong antioxidant via 
three different pathways including direct 
elimination of free radicals (Taleb et al., 2018), 
stopping the production of free radicals by 
inhibiting its associated enzymes (Zhu et al., 
2014) and maintaining optimal redox state of the 
cell by activating a wide range of enzymatic and 
non-enzymatic antioxidants through transcription 
factors (Surai, 2015).  
Silymarin was used as a strong 
antioxidant to overcome the oxidative stress-
induced toxicity by doxorubicin. The obtained 
results are consistent with Abdel Maksoud et al. 
(2019) who explained that Silybum marianum 
has hepatoprotective effects through anti-
inflammatory and antioxidants mechanisms. 
They also agree with Morales-González et al. 
(2015) who concluded the antioxidant activity of 
silymarin alarm its aptitude to reduce the free 
radicals that are produced from toxic substances 
metabolisms such as acetaminophen, 
carbon tetrachloride, and ethanol. 
The invention of free radicals is identified 
to break cellular membranes and reason 
lipoperoxidation. Hepatic glutathione was 
enhanced by Silymarin which may cause the 
contribution to the antioxidant protection of the 
liver and increases protein production in 
hepatocytes by motivating the activity of RNA  
polymerase I. 
Chemotherapeutic agents induce 
oxidative stress in patients which is responsible 
for its various side effects (Yokoyala et al., 
2017). Silymarin (active extract from milk thistle 
seeds) is known to have an antioxidant effect 
and offers protection against oxidative stress 
(Taleb et al., 2018). 
Our results are collinear with Kolarovic et 
al. (2010) who explained that Silymarin interacts 
with cell membranes increasing their resistance 
to harmful influences, mostly through changes in 
their physicochemical properties. They added 
that It also combine with free radicals converting 
them into less reactive and toxic compounds. 
Silymarin was also proved to inhibit lipid 
peroxidation and stimulating the production of 
glutathione. 
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CONCLUSION 
Patients treated with doxorubicin can 
take milk thistle extract as an additional 
supplement to overcome the side effects of 
chemotherapy. 
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